Outcomes of screening for hydroxychloroquine retinopathy at the Manchester Royal Eye Hospital: 2 years’ audit

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Xueting Yao, Fei Ye, Miao Zhang et al. · Clinical Infectious Diseases · 2020 · 2.8K citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

Martin J. Vincent, Éric Bergeron, Suzanne Benjannet et al. · Virology Journal · 2005 · 1.9K citations · Full text

Medicine, Infectious Diseases, Pharmacology +14

Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)

Michael F. Marmor, Ulrich Kellner, Timothy Y. Y. Lai et al. · Ophthalmology · 2016 · 1.2K citations · Full text

Medicine, Ophthalmology, Clinical Vision Science +11

The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy

Ronald B. Melles, Michael F. Marmor · JAMA Ophthalmology · 2014 · 681 citations

Medicine, Ophthalmology, Toxicology +13

Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus

Frederick Wolfe, Michael F. Marmor · Arthritis Care & Research · 2010 · 328 citations

Medicine, Ophthalmology, Ocular Disease +14